Works matching IS 00099236 AND DT 2021 AND VI 109 AND IP 2
Results: 34
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 283, doi. 10.1002/cpt.2139
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 285, doi. 10.1002/cpt.2147
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 279, doi. 10.1002/cpt.2138
- Publication type:
- Article
Translational Models and Tools to Reduce Clinical Trials and Improve Regulatory Decision Making for QTc and Proarrhythmia Risk (ICH E14/S7B Updates).
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 319, doi. 10.1002/cpt.2137
- By:
- Publication type:
- Article
Toward Replacement of Thorough QT Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 281, doi. 10.1002/cpt.2136
- By:
- Publication type:
- Article
Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 310, doi. 10.1002/cpt.2029
- By:
- Publication type:
- Article
Are Seniors Dependent on Benzodiazepines? A National Clinical Survey of Substance Use Disorder.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 528, doi. 10.1002/cpt.2025
- By:
- Publication type:
- Article
Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 536, doi. 10.1002/cpt.2024
- By:
- Publication type:
- Article
Model‐Based Meta‐Analysis Compares DAS28 Rheumatoid Arthritis Treatment Effects and Suggests an Expedited Trial Design for Early Clinical Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 517, doi. 10.1002/cpt.2023
- By:
- Publication type:
- Article
Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 507, doi. 10.1002/cpt.2022
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for Brain Cancer Treatment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 494, doi. 10.1002/cpt.2021
- By:
- Publication type:
- Article
Circulating miRNAs as Biomarkers for CYP2B6 Enzyme Activity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 485, doi. 10.1002/cpt.2018
- By:
- Publication type:
- Article
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug‐Drug Interaction Magnitudes in the Elderly.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 471, doi. 10.1002/cpt.2017
- By:
- Publication type:
- Article
Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 462, doi. 10.1002/cpt.2013
- By:
- Publication type:
- Article
Use of Real‐World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of Adjustment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 452, doi. 10.1002/cpt.2012
- By:
- Publication type:
- Article
Efficacy and Safety of Ticagrelor vs. Clopidogrel in East Asian Patients with Acute Myocardial Infarction: A Nationwide Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 443, doi. 10.1002/cpt.2011
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 302, doi. 10.1002/cpt.2008
- By:
- Publication type:
- Article
Quantitative Systems Toxicology Modeling Predicts that Reduced Biliary Efflux Contributes to Tolvaptan Hepatotoxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 433, doi. 10.1002/cpt.2007
- By:
- Publication type:
- Article
Integrated Mechanistic Model of Minimal Residual Disease Kinetics With Venetoclax Therapy in Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 424, doi. 10.1002/cpt.2005
- By:
- Publication type:
- Article
A Time‐to‐Event Model Relating Integrated Craving to Risk of Smoking Relapse Across Different Nicotine Replacement Therapy Formulations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 416, doi. 10.1002/cpt.2000
- By:
- Publication type:
- Article
International Collaboration in Real‐World Evidence Generation for Direct Acting Oral Anti‐Coagulants.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 299, doi. 10.1002/cpt.1999
- By:
- Publication type:
- Article
Model‐Informed Drug Development of the Masked Anti‑PD‑L1 Antibody CX‐072.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 383, doi. 10.1002/cpt.1985
- By:
- Publication type:
- Article
Response to "Strictness and Transparency in Approval Process of Medical Products: Japanese Situation".
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 291, doi. 10.1002/cpt.1996
- By:
- Publication type:
- Article
Strictness and Transparency in Approval Process of Medical Products: Japanese Situation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 290, doi. 10.1002/cpt.1994
- By:
- Publication type:
- Article
Exposure–Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non‐Small Cell Lung Cancer Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 394, doi. 10.1002/cpt.1989
- By:
- Publication type:
- Article
PMDA's Vision for Horizon Scanning of Emerging Technologies Potentially Relevant to the Development of New Medical Products: The Regulatory Challenge.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 295, doi. 10.1002/cpt.1986
- By:
- Publication type:
- Article
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 403, doi. 10.1002/cpt.1998
- By:
- Publication type:
- Article
Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012–2018.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 367, doi. 10.1002/cpt.1983
- By:
- Publication type:
- Article
Leveraging Clinical Pharmacology to Optimize Drug Development for Nonalcoholic Steatohepatitis and Cholestatic Liver Diseases: Workshop Report.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 292, doi. 10.1002/cpt.1978
- By:
- Publication type:
- Article
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 372, doi. 10.1002/cpt.1974
- By:
- Publication type:
- Article
PharmVar GeneFocus: CYP2C19.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 352, doi. 10.1002/cpt.1973
- By:
- Publication type:
- Article
Historical Controls in Randomized Clinical Trials: Opportunities and Challenges.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 343, doi. 10.1002/cpt.1970
- By:
- Publication type:
- Article
Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 334, doi. 10.1002/cpt.1946
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 271, doi. 10.1002/cpt.1896
- Publication type:
- Article